My pleasure. My take on the situation, and I try to stay current, is that the mRNA vaccines are by far the best of the lot. Even my business partner is coming to the U.S. to get a booster of Moderna, because he’s not satisfied with Astrazeneca’s track record. I received my second dose of Moderna in February, and I’m confident that we’re going to be offered boosters soon because, at some point, the virus will mutate to the point that the existing vaccines lose efficacy. Ivermectin as an adjunct to vaccination seems sensible to me.
My take on the situation, and I try to stay current, is that the mRNA vaccines are by far the best of the lot.
That’s not saying much.